{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:43:24Z","timestamp":1789785804675,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3592,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1093\/annonc\/mdp595","type":"journal-article","created":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T19:42:46Z","timestamp":1264707766000},"page":"195-198","source":"Crossref","is-referenced-by-count":39,"title":["Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)"],"prefix":"10.1016","volume":"21","author":[{"given":"R.","family":"Colomer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gonz\u00e1lez-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Paz-Ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Llombart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Rodr\u00edguez Lescure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Albanell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Isla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Germ\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bellmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tabernero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cubedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Baselga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdp595_bb0010","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/annonc\/mdm122","article-title":"National integration of European standards","volume":"18","author":"Bajetta","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdp595_bb0015","unstructured":"ESMO. Medical Oncology Status in Europe Survey (MOSES). http:\/\/www.esmo.org\/policy\/status-of-medical-oncology-in-europe.html"},{"key":"10.1093\/annonc\/mdp595_bb0020","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/annonc\/mdh447","article-title":"Recommendations for a global core curriculum in Medical Oncology","volume":"15","author":"Hansen","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdp595_bb0025","unstructured":"EMEA. EPARs for authorised medicinal products for human use. http:\/\/www.emea.europa.eu\/htms\/human\/epar\/a.htm"},{"key":"10.1093\/annonc\/mdp595_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1200\/JCO.2007.15.4088","article-title":"Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening\u2014a report from the American Society of Clinical Oncology","volume":"26","author":"Gralow","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp595_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.2005.04.8678","article-title":"Clinical cancer advances 2005: major research advances in cancer treatment, prevention, and screening\u2014a report from the American Society of Clinical Oncology","volume":"24","author":"Herbst","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp595_bb0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1200\/JCO.2006.09.7030","article-title":"Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening\u2014a report from the American Society of Clinical Oncology","volume":"25","author":"Ozols","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp595_bb0045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1200\/JCO.2008.21.2134","article-title":"Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening\u2014a report from the American Society of Clinical Oncology","volume":"27","author":"Winer","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp595_bb0050","unstructured":"Medicines in Development for Cancerhttp:\/\/www.phrma.org\/medicines_in_development_for_cancer\/"},{"key":"10.1093\/annonc\/mdp595_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10549-005-3376-y","article-title":"Perception that oral anticancer treatments are less efficacious: development of a questionnaire to assess the possible prejudices of patients with cancer","volume":"92","author":"Catania","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mdp595_bb0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lungcan.2008.02.009","article-title":"Randomized cross-over study of patient preference for oral or intravenous vinorelbine in combination with carboplatin in the treatment of advanced NSCLC","volume":"62","author":"Jensen","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdp595_bb0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.1997.15.1.110","article-title":"Patient preferences for oral versus intravenous palliative chemotherapy","volume":"15","author":"Liu","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp595_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/bjoc.1999.0866","article-title":"Position. paper by the UKCCCR elderly cancer patients in clinical trials working group","volume":"82","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdp595_bb0075","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/annonc\/mdm517","article-title":"The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)","volume":"18","author":"Casali","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdp595_bb0080","unstructured":"Estatutos de la Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM)http:\/\/www.seom.org\/seomcms\/images\/stories\/recursos\/conoceseom\/asociarse\/2006\/estatutos.pdf"},{"key":"10.1093\/annonc\/mdp595_bb0085","first-page":"38122","article-title":"19086-ORDEN SCO\/3370\/2006, de 9 de octubre, por la que se aprueba y publica el programa formativo de la especialidad de Oncolog\u00eda M\u00e9dica","volume":"262","author":"Medical Oncology Training Program","year":"2006","journal-title":"Bol Of Estado"},{"key":"10.1093\/annonc\/mdp595_bb0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdp595_bb0095","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.ejca.2005.04.005","article-title":"RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma","volume":"41","author":"Therasse","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdp595_bb0100","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1200\/JCO.2006.07.3411","article-title":"We should desist using RECIST, at least in GIST","volume":"25","author":"Benjamin","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp595_bb0105","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-08-2034","article-title":"Alternate endpoints for screening phase II studies","author":"Dhani","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419387885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419387885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/2\/195\/934970\/mdp595.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T03:16:18Z","timestamp":1624504578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419387885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0923753419387885"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdp595","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}